(NASDAQ:PSTV), HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced it has completed a Type B meeting with the U.S. Food and Drug Administration (FDA) on November 7th to discuss its REYOBIQ clinical […]

(NASDAQ:DFLI),(NASDAQ:DFLIW), Werner Enterprises, Inc. (Nasdaq: WERN) has placed their first order for Battle Born(R) DualFlow Power Pack systems following an extensive long-term pilot with Dragonfly Energy. The lithium-powered, American-assembled systems provide reliable hotel load power during rest periods: reducing idling, fuel consumption, and emissions. The order marks a key commercial milestone in Dragonfly Energy's expansion

(NASDAQ:NSPR), MIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard(R) Prime carotid stent system for the prevention of stroke, welcomes the recent presentation and publication of CREST-2 data which demonstrated positive clinical outcomes for carotid artery stenting (CAS) for patients with asymptomatic carotid stenosis. CREST-2

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=178866&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

GXO Announces Completion of Inaugural European Bond Offering GlobeNewswire November 24, 2025 GREENWICH, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world's largest pure-play contract logistics provider, today announced the completion of its inaugural European bond offering, with its wholly owned subsidiary GXO Logistics Capital B.V. issuing EUR500m in senior

Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ(TM) in Leptomeningeal Metastases GlobeNewswire November 24, 2025 HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced it has

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting Carotid artery stenting combined with medical therapy demonstrated a significantly lower stroke risk compared to intensive medical therapy alone in patients with severe asymptomatic carotid stenosis GlobeNewswire November 24, 2025 MIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) —

Antalpha Announces $10 Million Share Repurchase Program GlobeNewswire November 24, 2025 SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”) today announced that its board of directors has authorized a share repurchase program of up to $10 million of the Company's ordinary shares. The program will remain

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million GlobeNewswire November 24, 2025 CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ(R) MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug development GlobeNewswire November 24, 2025 SEATTLE, Nov. 24, 2025 (GLOBE